| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Gabrielle A Carlson, Michael Potegal, David Margulies, Joann Basile, Zinoviy Gutkovic. Liquid risperidone in the treatment of rages in psychiatrically hospitalized children with possible bipolar disorder. Bipolar disorders. vol 12. issue 2. 2010-09-22. PMID:20402713. |
to examine the safety and efficacy of liquid risperidone to reduce duration of rages in children with severe mood dysregulation (smd) or possible bipolar disorder (bp). |
2010-09-22 |
2023-08-12 |
Not clear |
| Emma D Deek. Risperidone long-acting injection: in bipolar I disorder. Drugs. vol 70. issue 8. 2010-08-09. PMID:20481656. |
maintenance treatment with risperidone long-acting injection was generally well tolerated in patients with bipolar disorder, both as monotherapy and adjunctive therapy, with most adverse reactions being of mild to moderate severity. |
2010-08-09 |
2023-08-12 |
Not clear |
| Andrea Fagiolini, Francesco Casamassima, Wilmer Mostacciuolo, Rocco Forgione, Arianna Goracci, Benjamin I Goldstei. Risperidone long-acting injection as monotherapy and adjunctive therapy in the maintenance treatment of bipolar I disorder. Expert opinion on pharmacotherapy. vol 11. issue 10. 2010-08-02. PMID:20486830. |
risperidone long-acting injection (lai) has proven efficacious for the maintenance phase of bipolar disorder and may mitigate the problem of nonadherence in the substantial group of patients for whom this is a significant concern. |
2010-08-02 |
2023-08-12 |
human |
| Rosaria Di Lorenzo, Susanna Genedan. Atypical antipsychotics in the therapy of bipolar disorders: efficacy and safety. Expert review of neurotherapeutics. vol 2. issue 3. 2010-06-25. PMID:19810868. |
the most significant studies published up to now, concerning the use of clozapine, olanzapine, risperidone, quetiapine and ziprasidone in bipolar disorders are reviewed here. |
2010-06-25 |
2023-08-12 |
Not clear |
| Yonghua Jing, Edward Kim, Min You, Andrei Pikalov, Quynh-Van Tra. Healthcare costs associated with treatment of bipolar disorder using a mood stabilizer plus adjunctive aripiprazole, quetiapine, risperidone, olanzapine or ziprasidone. Journal of medical economics. vol 12. issue 2. 2010-03-03. PMID:19527195. |
healthcare costs associated with treatment of bipolar disorder using a mood stabilizer plus adjunctive aripiprazole, quetiapine, risperidone, olanzapine or ziprasidone. |
2010-03-03 |
2023-08-12 |
Not clear |
| Cem Sengul, Ozgür Kalkanci, Deniz Simsek, Hasan Herke. Maintenance electroconvulsive therapy combined with long-acting risperidone in the treatment of resistant bipolar affective disorder. The journal of ECT. vol 25. issue 4. 2010-02-17. PMID:19440160. |
we present a middle-aged man with refractory bipolar disorder who was successfully treated with maintenance electroconvulsive therapy and long-acting risperidone. |
2010-02-17 |
2023-08-12 |
Not clear |
| Wayne Macfadden, Larry Alphs, J Thomas Haskins, Norris Turner, Ibrahim Turkoz, Cynthia Bossie, Mary Kujawa, Ramy Mahmou. A randomized, double-blind, placebo-controlled study of maintenance treatment with adjunctive risperidone long-acting therapy in patients with bipolar I disorder who relapse frequently. Bipolar disorders. vol 11. issue 8. 2010-01-27. PMID:19922552. |
this study assessed whether adjunctive maintenance treatment with risperidone long-acting therapy (rlat), added to treatment-as-usual (tau) medications for bipolar disorder, delays relapse in patients with bipolar disorder type i. |
2010-01-27 |
2023-08-12 |
Not clear |
| Magali Haas, Melissa P Delbello, Gahan Pandina, Stuart Kushner, Ilse Van Hove, Ilse Augustyns, Jorge Quiroz, Vivek Kusumaka. Risperidone for the treatment of acute mania in children and adolescents with bipolar disorder: a randomized, double-blind, placebo-controlled study. Bipolar disorders. vol 11. issue 7. 2010-01-01. PMID:19839994. |
risperidone for the treatment of acute mania in children and adolescents with bipolar disorder: a randomized, double-blind, placebo-controlled study. |
2010-01-01 |
2023-08-12 |
Not clear |
| David E Kemp, Fatih Canan, Benjamin I Goldstein, Roger S McIntyr. Long-acting risperidone: a review of its role in the treatment of bipolar disorder. Advances in therapy. vol 26. issue 6. 2009-12-11. PMID:19562274. |
long-acting risperidone: a review of its role in the treatment of bipolar disorder. |
2009-12-11 |
2023-08-12 |
Not clear |
| David E Kemp, Fatih Canan, Benjamin I Goldstein, Roger S McIntyr. Long-acting risperidone: a review of its role in the treatment of bipolar disorder. Advances in therapy. vol 26. issue 6. 2009-12-11. PMID:19562274. |
this article will provide a succinct review of the latest data on the use of long-acting injectable risperidone (lar) during the maintenance-phase treatment of bipolar disorder. |
2009-12-11 |
2023-08-12 |
Not clear |
| Edward Kim, Ross Maclean, Diane Ammerman, Yonghua Jing, Andrei Pikalov, Min You, Quynh Van-Tran, Gilbert L'Italie. Time to psychiatric hospitalization in patients with bipolar disorder treated with a mood stabilizer and adjunctive atypical antipsychotics: a retrospective claims database analysis. Clinical therapeutics. vol 31. issue 4. 2009-07-27. PMID:19446157. |
this study compared the time to psychiatric hospitalization in commercially insured patients with bipolar disorder who were treated with a mood stabilizer plus adjunctive aripiprazole versus adjunctive ziprasidone, olanzapine, quetiapine, or risperidone. |
2009-07-27 |
2023-08-12 |
Not clear |
| Claire Chevreuil, Jean-Michel Reymann, Tanya Frémaux, Elisabeth Polard, Tanguy Séveno, Danièle Bentué-Ferre. [Risperidone use in child and adolescent psychiatric patients]. Therapie. vol 63. issue 5. 2009-04-27. PMID:19154706. |
risperidone has proved helpful in treating children and adolescents with autism spectrum, conduct and bipolar disorders, tourette's syndrome, and schizophrenia. |
2009-04-27 |
2023-08-12 |
Not clear |
| Samuel Keit. Use of long-acting risperidone in psychiatric disorders: focus on efficacy, safety and cost-effectiveness. Expert review of neurotherapeutics. vol 9. issue 1. 2009-03-03. PMID:19102665. |
this article discusses the efficacy, tolerability and cost-effectiveness of long-acting risperidone in schizophrenia and bipolar disorder patients, and suggests possibilities for how its role in clinical practice may change over the next 5 years. |
2009-03-03 |
2023-08-12 |
Not clear |
| Carlene M MacMillan, Jane E Withney, Sergio R Korndörfer, Claire A Tilley, Christine Mrakotsky, Joseph M Gonzalez-Heydric. Comparative clinical responses to risperidone and divalproex in patients with pediatric bipolar disorder. Journal of psychiatric practice. vol 14. issue 3. 2008-09-02. PMID:18520785. |
comparative clinical responses to risperidone and divalproex in patients with pediatric bipolar disorder. |
2008-09-02 |
2023-08-12 |
Not clear |
| Carlene M MacMillan, Jane E Withney, Sergio R Korndörfer, Claire A Tilley, Christine Mrakotsky, Joseph M Gonzalez-Heydric. Comparative clinical responses to risperidone and divalproex in patients with pediatric bipolar disorder. Journal of psychiatric practice. vol 14. issue 3. 2008-09-02. PMID:18520785. |
to compare clinical responses of patients with pediatric bipolar disorder being treated with risperidone versus divalproex. |
2008-09-02 |
2023-08-12 |
Not clear |
| Rao N Malempati, David J Bond, Lakshmi N Yatha. Depot risperidone in the outpatient management of bipolar disorder: a 2-year study of 10 patients. International clinical psychopharmacology. vol 23. issue 2. 2008-05-07. PMID:18301123. |
depot risperidone in the outpatient management of bipolar disorder: a 2-year study of 10 patients. |
2008-05-07 |
2023-08-12 |
Not clear |
| L N Yatham, A Fallu, C E Binde. A 6-month randomized open-label comparison of continuation of oral atypical antipsychotic therapy or switch to long acting injectable risperidone in patients with bipolar disorder. Acta psychiatrica Scandinavica. Supplementum. issue 434. 2007-12-21. PMID:17688463. |
a 6-month randomized open-label comparison of continuation of oral atypical antipsychotic therapy or switch to long acting injectable risperidone in patients with bipolar disorder. |
2007-12-21 |
2023-08-12 |
Not clear |
| Changsu Han, Moon-Soo Lee, Chi-Un Pae, Young-Hoon Ko, Ashwin A Patkar, In-Kwa Jun. Usefulness of long-acting injectable risperidone during 12-month maintenance therapy of bipolar disorder. Progress in neuro-psychopharmacology & biological psychiatry. vol 31. issue 6. 2007-10-31. PMID:17532106. |
usefulness of long-acting injectable risperidone during 12-month maintenance therapy of bipolar disorder. |
2007-10-31 |
2023-08-12 |
human |
| Philip D Harvey, Howard Hassman, Lian Mao, Georges M Gharabawi, Ramy A Mahmoud, Luella M Engelhar. Cognitive functioning and acute sedative effects of risperidone and quetiapine in patients with stable bipolar I disorder: a randomized, double-blind, crossover study. The Journal of clinical psychiatry. vol 68. issue 8. 2007-09-24. PMID:17854242. |
the primary objective of this double-blind study was to compare the effects of treatment initiation with risperidone and quetiapine on cognitive function in subjects with stable bipolar disorder. |
2007-09-24 |
2023-08-12 |
human |
| Constance M Moore, Joseph Biederman, Janet Wozniak, Eric Mick, Megan Aleardi, Megan Wardrop, Meghan Dougherty, Terri Harpold, Paul Hammerness, Edin Randall, In Kyoon Lyoo, Perry F Rensha. Mania, glutamate/glutamine and risperidone in pediatric bipolar disorder: a proton magnetic resonance spectroscopy study of the anterior cingulate cortex. Journal of affective disorders. vol 99. issue 1-3. 2007-06-14. PMID:17005256. |
mania, glutamate/glutamine and risperidone in pediatric bipolar disorder: a proton magnetic resonance spectroscopy study of the anterior cingulate cortex. |
2007-06-14 |
2023-08-12 |
human |